menu
    • menu

    Company profile for Axsome Therapeutics

    NEW Drugs in Dev: 10
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We aim to become a fully integrated biopharmaceutical company that develops and commercializes differentiated medicines that expand the treatment options available to caregivers and improve the lives of patients living with CNS disorders. Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders for which there are limited tre...
    We aim to become a fully integrated biopharmaceutical company that develops and commercializes differentiated medicines that expand the treatment options available to caregivers and improve the lives of patients living with CNS disorders. Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders for which there are limited treatment options. Axsome's core CNS product candidate portfolio includes four clinical-stage candidates, which we are developing for six different CNS indications.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Axsome TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    200 Broadway, 3rd Floor New York, NY 10038
    Telephone
    Telephone
    +1 (212) 332-3241
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.axsome.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/axsome-therapeutics-inc-
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Axsome Therapeutics Reports Q1 2026 Results and Business Update
    Axsome Therapeutics Reports Q1 2026 Results and Business Update

    04 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/04/3286568/33090/en/axsome-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update.html

    GLOBENEWSWIRE
    04 May 2026
    Share Share
    US FDA approves Axsome's drug for Alzheimer's-related agitation
    US FDA approves Axsome's drug for Alzheimer's-related agitation

    30 Apr 2026

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-axsomes-drug-alzheimers-related-agitation-2026-04-30/

    REUTERS
    30 Apr 2026
    Share Share
    Axsome Therapeutics to Report Q1 2026 Results on May 4
    Axsome Therapeutics to Report Q1 2026 Results on May 4

    08 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/08/3269965/33090/en/Axsome-Therapeutics-to-Report-First-Quarter-2026-Financial-Results-on-May-4.html

    GLOBENEWSWIRE
    08 Apr 2026
    Share Share
    Axsome Acquires PDE10A Inhibitor Balipodect for Schizophrenia
    Axsome Acquires PDE10A Inhibitor Balipodect for Schizophrenia

    01 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/01/3266474/33090/en/Axsome-Therapeutics-Acquires-Selective-PDE10A-Inhibitor-Balipodect-for-the-Treatment-of-Schizophrenia-and-Other-Neuropsychiatric-Conditions.html

    GLOBENEWSWIRE
    01 Apr 2026
    Share Share
    Axsome Therapeutics Joins Investor Conferences
    Axsome Therapeutics Joins Investor Conferences

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3244451/33090/en/Axsome-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share
    Axsome Launches Solriamfetol CLARITY Phase 3 Trial in MDD
    Axsome Launches Solriamfetol CLARITY Phase 3 Trial in MDD

    24 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/24/3243362/33090/en/Axsome-Therapeutics-Initiates-CLARITY-Phase-3-Trial-of-Solriamfetol-in-Adults-with-Major-Depressive-Disorder-with-Excessive-Daytime-Sleepiness-Symptoms.html

    GLOBENEWSWIRE
    24 Feb 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search